Product Details
| Product Name: Ubrogepant | CAS No.: 1374248-77-7 |
| Min. Order: 1KG | Purity: 98% |
| Supply Ability: 1000KGS | Release date: 2025/03/21 |
Email: sales@anbuchem.com
Whatsapp:+8618638608485
24 hours online, Welcom to inquiry.
| Ubrogepant Basic information |
Product Name: Ubrogepant
Synonyms: Ubrogepant;MK-1602;MK-1602 Ubrogepant;Spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1',2',5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2'-oxo-, (3'S)-;Ubrogepant API;Ubrogepant D5;(S)-N-((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide;MK1602,MK 1602,Ubrogepant,inhibit,Inhibitor,Calcitonin gene-related peptide receptor,CGRP Receptor
CAS: 1374248-77-7
MF: C29H26F3N5O3
MW: 549.54
EINECS:
Product Categories: API;1374248-77-7
Mol File: 1374248-77-7.mol
Ubrogepant Structure
Ubrogepant Chemical Properties
Boiling point 729.4±60.0 °C(Predicted)
density 1.45±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble in DMSO
pka 11.08±0.20(Predicted)
Safety Information
MSDS Information
Ubrogepant Usage And Synthesis
Uses Ubrogepant, is a new drug possible used for the treatment of migraine.
Company Profile Introduction
You may like
-
CAS:241479-67-4
-
CAS:1375541-21-1
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2.00 |
VIP2Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2026-07-02 | |
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 | ||
|
VIP4Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2026-01-04 | ||
| $155.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-04-20 |

China